Itama Ranoraya (IRRA) - Net Assets

Latest as of September 2025: Rp556.81 Billion IDR ≈ $32.63 Million USD

Based on the latest financial reports, Itama Ranoraya (IRRA) has net assets worth Rp556.81 Billion IDR (≈ $32.63 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp2.72 Trillion ≈ $159.47 Million USD) and total liabilities (Rp2.16 Trillion ≈ $126.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check IRRA cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets Rp556.81 Billion
% of Total Assets 20.46%
Annual Growth Rate 62.04%
5-Year Change 111.41%
10-Year Change N/A
Growth Volatility 116.68

Itama Ranoraya - Net Assets Trend (2016–2024)

This chart illustrates how Itama Ranoraya's net assets have evolved over time, based on quarterly financial data. Also explore how large is Itama Ranoraya's balance sheet for the complete picture of this company's asset base.

Annual Net Assets for Itama Ranoraya (2016–2024)

The table below shows the annual net assets of Itama Ranoraya from 2016 to 2024. For live valuation and market cap data, see IRRA company net worth.

Year Net Assets Change
2024-12-31 Rp512.31 Billion
≈ $30.02 Million
+11.57%
2023-12-31 Rp459.20 Billion
≈ $26.91 Million
-5.13%
2022-12-31 Rp484.04 Billion
≈ $28.36 Million
-3.59%
2021-12-31 Rp502.05 Billion
≈ $29.42 Million
+107.18%
2020-12-31 Rp242.33 Billion
≈ $14.20 Million
+3.05%
2019-12-31 Rp235.17 Billion
≈ $13.78 Million
+252.88%
2018-12-31 Rp66.64 Billion
≈ $3.91 Million
+50.27%
2017-12-31 Rp44.35 Billion
≈ $2.60 Million
+311.36%
2016-12-31 Rp10.78 Billion
≈ $631.71K
--

Equity Component Analysis

This analysis shows how different components contribute to Itama Ranoraya's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 89251.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings Rp249.66 Billion 48.73%
Common Stock Rp75.39 Billion 14.72%
Other Comprehensive Income Rp-652.95 Million -0.13%
Other Components Rp187.91 Billion 36.68%
Total Equity Rp512.31 Billion 100.00%

Itama Ranoraya Competitors by Market Cap

The table below lists competitors of Itama Ranoraya ranked by their market capitalization.

Company Market Cap
BG T&A Co
KQ:046310
$34.14 Million
Mobileleader Co.Ltd
KQ:100030
$34.15 Million
Cypherpunk Technologies Inc.
NASDAQ:CYPH
$34.16 Million
Yuhwa Securities Co Ltd
KO:003465
$34.18 Million
Accentis
BR:ACCB
$34.10 Million
KebNi AB (publ)
ST:KEBNI-B
$34.09 Million
ALPHA EXPLORATION LTD
F:J0C
$34.09 Million
BRIDGETEC Corp
KQ:064480
$34.09 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Itama Ranoraya's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 459,201,214,256 to 512,312,964,000, a change of 53,111,749,744 (11.6%).
  • Net income of 53,263,191,000 contributed positively to equity growth.
  • Other comprehensive income decreased equity by 151,441,340.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Rp53.26 Billion +10.4%
Other Comprehensive Income Rp-151.44 Million -0.03%
Other Changes Rp84.00 +0.0%
Total Change Rp- 11.57%

Book Value vs Market Value Analysis

This analysis compares Itama Ranoraya's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.14x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 57.29x to 1.14x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 Rp6.74 Rp386.00 x
2017-12-31 Rp27.72 Rp386.00 x
2018-12-31 Rp41.65 Rp386.00 x
2019-12-31 Rp146.98 Rp386.00 x
2020-12-31 Rp159.32 Rp386.00 x
2021-12-31 Rp326.78 Rp386.00 x
2022-12-31 Rp309.34 Rp386.00 x
2023-12-31 Rp297.37 Rp386.00 x
2024-12-31 Rp339.77 Rp386.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Itama Ranoraya utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 10.40%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 5.45%
  • • Asset Turnover: 0.59x
  • • Equity Multiplier: 3.24x
  • Recent ROE (10.40%) is below the historical average (21.32%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 6.56% 5.44% 0.48x 2.52x Rp-371.37 Million
2017 54.06% 10.65% 1.76x 2.88x Rp19.54 Billion
2018 48.41% 12.15% 1.95x 2.04x Rp25.60 Billion
2019 14.12% 11.79% 0.87x 1.38x Rp9.69 Billion
2020 24.97% 10.73% 1.05x 2.21x Rp36.29 Billion
2021 22.34% 8.50% 1.69x 1.56x Rp61.95 Billion
2022 9.92% 6.37% 1.03x 1.52x Rp-399.81 Million
2023 1.13% 0.75% 0.66x 2.31x Rp-40.72 Billion
2024 10.40% 5.45% 0.59x 3.24x Rp2.03 Billion

Industry Comparison

This section compares Itama Ranoraya's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $485,035,106,686
  • Average return on equity (ROE) among peers: 42.83%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Itama Ranoraya (IRRA) Rp556.81 Billion 6.56% 3.89x $34.10 Million
Enseval Putra Megatrading Tbk (EPMT) $576.81 Billion 31.08% 1.87x $374.57 Million
Kimia Farma Persero Tbk (KAEF) $1.25 Trillion 13.71% 0.43x $155.91 Million
Millennium Pharmacon International (SDPC) $104.62 Billion 9.41% 2.69x $14.11 Million
Dosni Roha Indonesia Tbk PT (ZBRA) $6.20 Billion 117.13% 11.72x $117.43K

About Itama Ranoraya

JK:IRRA Indonesia Medical Distribution
Market Cap
$34.10 Million
Rp582.02 Billion IDR
Market Cap Rank
#23275 Global
#485 in Indonesia
Share Price
Rp386.00
Change (1 day)
-1.53%
52-Week Range
Rp376.00 - Rp530.00
All Time High
Rp3619.99
About

PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more